In this CME, Ingrid Loma-Miller, MD, assistant division chief of the Multiple Sclerosis and Neuroimmunology Center, explains the use of disease modifying therapies during pregnancy and lactation, discusses how to counsel women who have multiple sclerosis and want to get pregnant, and more.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Explain the use of disease modifying therapies during pregnancy
- Explain the use of disease modifying therapies during lactation
- Learn about fertility and multiple sclerosis
- Implement how to counsel women who have multiple sclerosis and want to get pregnancy
- Learn how to treat Multiple Sclerosis relapses during pregnancy and after pregnancy
Disclosures:
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 11/18/2024 | Last Modified On: 11/18/2024 | Expires: 11/18/2025
Disclosure Description
Graham, E., Bove, R., Costello, K., Crayton, H., Jacobs, D., Shah, S., Sorrell, F., Stoll,S., Houtchens, M. Practical Considerations of Managing Pregnancy in Patients with Multiple Sclerosis. Dispelling the Myths 2024.Houtchens MK et al . Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: data from an administrative claims database. Mult Scler Relat Disord. 2020; 46:102541.
Graham EL, , et al. Inflammatory activity after diverse fertility treatments: a multicenter analysis in the modern multiple sclerosis treatment era. Neurol Neuroimmunol Neuroinflamm. 2023;10(3):e200106.
Krysko,K et al. Family planning considerations in people with multiple sclerosis. Lancet Neurol 2022; 22: 350-366
Haghikia et al. Natalizumab use during the third trimester of pregnancy. JAMA Neurol 2014. 71: 891-895
